951PA phase Ib study of navicixizumab & weekly paclitaxel in heavily pre-treated platinum resistant ovarian, primary peritoneal or fallopian tube cancer. (23rd October 2018) - Fu, S; Corr, B; Hamilton, E; Burger, R A; Wenham, R; Naumann, R W; Stagg, R; Moore, K N